Rhumbline Advisers Summit Therapeutics Inc. Transaction History

Rhumbline Advisers

  • $121 Billion
  • Q3 2025

A detailed history of Rhumbline Advisers transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 122,922 shares of SMMT stock, worth $2.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
122,922
Previous 122,394 0.43%
Holding current value
$2.24 Million
Previous $2.6 Million 2.15%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025
BUY
$17.61 - $30.02 $9,298 - $15,850
528 Added 0.43%
122,922 $2.55 Million
Q2 2025

Aug 12, 2025
SELL
$16.64 - $36.7 $155,850 - $343,732
-9,366 Reduced 7.11%
122,394 $2.6 Million
Q1 2025

Apr 08, 2025
BUY
$16.65 - $23.76 $109,190 - $155,818
6,558 Added 5.24%
131,760 $2.68 Million
Q4 2024

May 29, 2025
SELL
$17.52 - $23.46 $114,896 - $153,850
-6,558 Reduced 4.98%
125,202 $2.23 Million
Q4 2024

Jan 30, 2025
BUY
$17.52 - $23.46 $94,502 - $126,543
5,394 Added 4.5%
125,202 $2.23 Million
Q3 2024

Nov 12, 2024
SELL
$6.89 - $31.93 $60,707 - $281,335
-8,811 Reduced 6.85%
119,808 $2.62 Million
Q2 2024

Aug 01, 2024
SELL
$2.39 - $10.92 $28,737 - $131,302
-12,024 Reduced 8.55%
128,619 $1 Million
Q1 2024

May 09, 2024
BUY
$2.55 - $5.07 $17,676 - $35,145
6,932 Added 5.18%
140,643 $582,000
Q4 2023

Feb 08, 2024
BUY
$1.67 - $2.83 $708 - $1,199
424 Added 0.32%
133,711 $348,000
Q3 2023

Nov 09, 2023
BUY
$1.54 - $2.42 $9,333 - $14,667
6,061 Added 4.76%
133,287 $249,000
Q2 2023

Aug 08, 2023
BUY
$1.32 - $2.81 $167,938 - $357,505
127,226 New
127,226 $319,000
Q2 2022

Aug 11, 2022
SELL
$0.92 - $2.38 $13,905 - $35,973
-15,115 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$2.0 - $3.45 $4,584 - $7,907
2,292 Added 17.87%
15,115 $37,000
Q4 2021

Feb 10, 2022
SELL
$2.45 - $5.64 $1,477 - $3,400
-603 Reduced 4.49%
12,823 $34,000
Q3 2021

Nov 12, 2021
BUY
$4.83 - $8.27 $4,385 - $7,509
908 Added 7.25%
13,426 $67,000
Q2 2021

Aug 05, 2021
BUY
$5.15 - $8.46 $64,467 - $105,902
12,518 New
12,518 $93,000

Others Institutions Holding SMMT

# of Institutions
264
Shares Held
94.3M
Call Options Held
4.72M
Put Options Held
4.03M
View Full List

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.67B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email